Staar Surgical rises after Stifel upgrades to buy and lifts price target
Stifel upgraded Staar Surgical to buy from hold, citing EVO+ lens adoption in China and improving international demand. The brokerage raised its PT to $31 from $28.
Stifel upgraded Staar Surgical to buy from hold, citing EVO+ lens adoption in China and improving international demand. The brokerage raised its PT to $31 from $28.